GGrantIndex
Sort

39,280 grants matching leukemia

Immunoglobulin and T Cell Receptor Gene Assembly

$324,630
David G. Schatz · Yale University · R37 · FY2008 · AI

Eastern Cooperative Oncology Group

$324,627
Patrick J Loehrer · Indiana Univ-Purdue Univ At Indianapolis · U10 · FY2007 · CA

Eastern Cooperative Oncology Group

$324,626
Patrick J Loehrer · Indiana Univ-Purdue Univ At Indianapolis · U10 · FY2006 · CA

The role of AKT signaling in NOTCH1 induced leukemias

$324,613
Adolfo A. Ferrando · Columbia University Health Sciences · R01 · FY2012 · CA

The role of AKT signaling in NOTCH1 induced leukemias

$324,598
Adolfo A. Ferrando · Columbia University Health Sciences · R01 · FY2011 · CA

Cancer Biology Training Program

$324,577
University Of Nebraska Medical Center · T32 · FY2004 · CA

Molecular mechanism of chromatin targeting by BRPF1

$324,560
Tatiana G Kutateladze · University Of Colorado Denver · R01 · FY2015 · GM

???Novel melampomagnolide B-based prodrugs for the treatment of leukemia???

$324,557
Peter Anthony Crooks · Univ Of Arkansas For Med Scis · R01 · FY2011 · CA

SOUTHWEST ONCOLOGY GROUP

$324,550
Louisiana State Univ Hsc Shreveport · U10 · FY2002 · CA

Project 3: Oncogenic triggers and their influence on 3D chromosomal architecture

$324,528
Iannis Aifantis · New York University School Of Medicine · P01 · FY2022 · CA

TUMOR PROMOTER MACROPHAGE DIFFERENTIATION AND APOPTOSIS

$324,499
University Of Chicago · R01 · FY2001 · CA

Myeloid cell function in muscle injury and repair

$324,478
James G Tidball · University Of California Los Angeles · R01 · FY2008 · AR

Myeloid cell function in muscle injury and repair

$324,478
James G Tidball · University Of California Los Angeles · R01 · FY2009 · AR

ONCOGENIC ACTIVATION OF MYB FAMILY PROTEINS

$324,476
Stanford University · R01 · FY2000 · CA

IMMUNE MONITORING CORE

$324,451
Trudy Nan Small · Sloan-Kettering Inst Can Research · P01 · FY2011 · CA

Project 4 - Targeting AML using novel bispecific and antibody-drug conjugates.

$324,449
John F Dipersio · Washington University · P50 · FY2020 · CA

Therapy-Related Leukemia Following Autologous Transplantation for Lymphoma

$324,440
Ravi Bhatia · Beckman Research Institute/City Of Hope · P50 · FY2007 · CA

The role of microRNAs in leukemic initiation and maintenance

$324,433
Jun Lu · Yale University · R01 · FY2013 · CA

CRLF2 signaling in B-cell acute lymphoblastic leukemia

$324,410
David Marc Weinstock · Dana-Farber Cancer Inst · R01 · FY2014 · CA

HEMATOPOIESIS AND LEUKEMIC TRANSFORMATION IN FAC MICE

$324,407
Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2003 · HL

Nanopatterned Surfaces to Control Cell Fate

$324,387
Kevin E Healy · University Of California Berkeley · R01 · FY2012 · GM

Targeting Janus kinases in the treatment of autoimmune disease

$324,354
John O'Shea · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2015 · AR

Tax regulation of HTLV-I Gene Expression through CBP

$324,346
Jennifer K. Nyborg · Colorado State University · R01 · FY2007 · CA

Tax regulation of HTLV-I Gene Expression through CBP

$324,346
Jennifer K. Nyborg · Colorado State University · R01 · FY2008 · CA

Biochemical and Molecular Studies on DT Diaphorase

$324,284
David Ross · University Of Colorado Denver · R01 · FY2007 · CA